Spyre Therapeutics
SYRE
SYRE
60 hedge funds and large institutions have $123M invested in Spyre Therapeutics in 2018 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.08% more ownership
Funds ownership: 2.65% → 2.74% (+0.08%)
12% less capital invested
Capital invested by funds: $140M → $123M (-$17.4M)
Holders
60
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$4.07M | |
| 2 | +$2.44M | |
| 3 | +$2.18M | |
| 4 |
BlackRock
New York
|
+$2.06M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$898K |
Top Sellers
| 1 | -$2.54M | |
| 2 | -$1.35M | |
| 3 | -$1.31M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$519K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$398K |